New hope for tough blood cancers: first test of promising pill begins
NCT ID NCT04883957
Summary
This is an early-stage study to find a safe dose of a new oral drug called BGB-11417 for adults with advanced B-cell cancers that have come back or stopped responding to standard treatments. The main goals are to check the drug's safety, see how the body processes it, and look for early signs that it might shrink tumors. The study will enroll about 64 people with specific types of lymphoma or leukemia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MATURE B-CELL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Zhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality, 200032, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450000, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
-
Peking University Peoples Hospital
Beijing, Beijing Municipality, 100044, China
-
Shenzhen Peoples Hospital
Shenzhen, Guangdong, 518020, China
-
Sun Yat Sen University Cancer Center
Guangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital of Nanchang University Branch Donghu
Nanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
-
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.